The slippery slope of HHS' transgender policy; Evolution of physical and mental health solutions

Invent Health with Dr. Archana Dubey and Bambi Francisco Roizen; Episode 6

The Invent Health weekly podcast with Dr. Archana Dubey and Bambi Francisco Roizen is the only weekly podcast that breaks down the latest digital health news of the week and what it means for patients, providers and payers (or who's paying). Plus a deep dive on a particular topic to help listeners understand how innovation is changing the healthcare paradigm.

This week, Archana and Bambi cover HHS' transgender policy that would make it easier for children experiencing gender dysphoria to get puberty blockers and other services. The two agree that the policy would be a slippery slope, as scientific studies have shown 60-90% of kids who experience this dysphoria grow out of it. There's also uncertainty as to what these hormone blockers would do to a child's mental facilities. The two also talk about Vida Health's more than $100 million raise and how it compares to the other players, Omaha Health, Virta Health, Livongo and more. Walmart buys MeMD. Does anyone care? 

Editor's note: On May 19 we will be hosting the Future of Mental and Behavioral Health 2021 virtual event. We'll have top-level VCs and C-level executives from the leading mental and behavioral companies, such as Teladoc's BetterHelp, Amwell, Doctor on Demand, Kaiser Permanente, Bessemer Ventures and more.